Evidence for the efficacy of NXY-059 in experimental focal cerebral ischaemia is confounded by study quality.

Translated title of the contribution: Evidence for the efficacy of NXY-059 in experimental focal cerebral ischaemia is confounded by study quality.

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Evidence for the efficacy of NXY-059 in experimental focal cerebral ischaemia is confounded by study quality.
Original language	Undefined/Unknown
Pages (from-to)	2824-2829
Number of pages	6
Journal	Stroke
Volume	39
Issue number	10
Publication status	Published - 2008

Cite this

@article{01c9d5b22daa49eb9ed0a1298dfb4ed1,

title = "Evidence for the efficacy of NXY-059 in experimental focal cerebral ischaemia is confounded by study quality.",

author = "M.R. Macleod and \{van der Worp\}, H.B. and E.S. Sena and D.W. Howells and U. Dirnagl and G.A. Donnan",

year = "2008",

language = "Undefined/Unknown",

volume = "39",

pages = "2824--2829",

journal = "Stroke",

issn = "0039-2499",

publisher = "Wolters Kluwer Health",

number = "10",

}